Programmed Death Ligand-1 Antagonists

Name
Programmed Death Ligand-1 Antagonists
Accession Number
DBCAT004242
Description

Not Available

Drugs
DrugDrug Description
AvelumabA monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma.
DurvalumabAn antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer.
Drugs & Drug Targets
DrugTargetType
AvelumabProgrammed cell death 1 ligand 1target
DurvalumabProgrammed cell death 1 ligand 1target